{"title":"[Holoxan治疗支气管小细胞癌的临床经验[作者简介]。","authors":"O Kokron, R Titscher, M Micksche, C Cerni, H Wrba","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Clinical experiences obtained until now in the treatment of 47 patients with small cell carcinoma of the bronchus with Holoxan are reported. Special emphasis is laid to the results of a prospective randomized study; two groups of patients, one of them undergoing Holoxan therapy, the other receiving symptomatic treatment, have been investigated in respect of relationship between tumour remission, quality of life and survival time.</p>","PeriodicalId":76295,"journal":{"name":"Osterreichische Zeitschrift fur Onkologie. Austrian journal of oncology","volume":"4 5-6","pages":"103-6"},"PeriodicalIF":0.0000,"publicationDate":"1977-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Clinical experiences with Holoxan in small cell carcinoma of the bronchus (author's transl)].\",\"authors\":\"O Kokron, R Titscher, M Micksche, C Cerni, H Wrba\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Clinical experiences obtained until now in the treatment of 47 patients with small cell carcinoma of the bronchus with Holoxan are reported. Special emphasis is laid to the results of a prospective randomized study; two groups of patients, one of them undergoing Holoxan therapy, the other receiving symptomatic treatment, have been investigated in respect of relationship between tumour remission, quality of life and survival time.</p>\",\"PeriodicalId\":76295,\"journal\":{\"name\":\"Osterreichische Zeitschrift fur Onkologie. Austrian journal of oncology\",\"volume\":\"4 5-6\",\"pages\":\"103-6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1977-11-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Osterreichische Zeitschrift fur Onkologie. Austrian journal of oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Osterreichische Zeitschrift fur Onkologie. Austrian journal of oncology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Clinical experiences with Holoxan in small cell carcinoma of the bronchus (author's transl)].
Clinical experiences obtained until now in the treatment of 47 patients with small cell carcinoma of the bronchus with Holoxan are reported. Special emphasis is laid to the results of a prospective randomized study; two groups of patients, one of them undergoing Holoxan therapy, the other receiving symptomatic treatment, have been investigated in respect of relationship between tumour remission, quality of life and survival time.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
